Oncothyreon (ONTY) CEO Robert Kirkman Retires; Christopher Henney Named Interim CEO
Tweet Send to a Friend
Oncothyreon Inc. (Nasdaq: ONTY) announced that Robert L. Kirkman, M.D., has retired as president and CEO and as a member ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE